|
🐜
|
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
23 auth.
L. Richeldi,
R. D. du Bois,
G. Raghu,
A. Azuma,
K. Brown,
U. Costabel,
V. Cottin,
K. Flaherty,
D. Hansell,
Y. Inoue,
...
D. S. Kim,
M. Kolb,
A. Nicholson,
P. Noble,
M. Selman,
H. Taniguchi,
M. Brun,
F. Le Maulf,
M. Girard,
S. Stowasser,
R. Schlenker‐Herceg,
B. Disse,
H. Collard
|
10 |
2014 |
10
🐜
|
|
🐜
|
Interstitial lung disease in systemic sclerosis: a simple staging system.
15 auth.
N. Goh,
S. Desai,
S. Veeraraghavan,
D. Hansell,
S. Copley,
T. Maher,
T. Corte,
C. Sander,
J. Ratoff,
A. Devaraj,
...
G. Bozovic,
C. Denton,
C. Black,
R. D. du Bois,
A. Wells
|
9 |
2008 |
9
🐜
|
|
🐢
|
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
15 auth.
L. Richeldi,
U. Costabel,
M. Selman,
D. S. Kim,
D. Hansell,
A. Nicholson,
K. Brown,
K. Flaherty,
P. Noble,
G. Raghu,
...
M. Brun,
Abhya Gupta,
N. Juhel,
M. Klüglich,
R. D. du Bois
|
9 |
2011 |
9
🐢
|
|
🐜
|
A common MUC5B promoter polymorphism and pulmonary fibrosis.
29 auth.
M. Seibold,
A. L. Wise,
M. Speer,
M. Steele,
K. Brown,
J. Loyd,
T. Fingerlin,
Weiming Zhang,
G. Gudmundsson,
S. Groshong,
C. Evans,
S. Garantziotis,
K. Adler,
B. Dickey,
R. D. du Bois,
...
Ivana V. Yang,
A. Herron,
D. Kervitsky,
Janet L. Talbert,
C. Markin,
Joungjoa Park,
A. Crews,
S. Slifer,
S. Auerbach,
Michelle G. Roy,
Jia Lin,
Corinne E. Hennessy,
M. Schwarz,
D. Schwartz
|
9 |
2011 |
9
🐜
|
|
🐜
|
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
19 auth.
A. Fischer,
K. Antoniou,
K. Brown,
J. Cadranel,
T. Corte,
R. D. du Bois,
Joyce S. Lee,
K. Leslie,
D. Lynch,
E. Matteson,
...
M. Mosca,
I. Noth,
L. Richeldi,
M. Strek,
J. Swigris,
A. Wells,
S. West,
H. Collard,
V. Cottin
|
9 |
2015 |
9
🐜
|
|
🐢
|
Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.
10 auth.
D. Bouros,
A. Wells,
A. Nicholson,
T. Colby,
V. Polychronopoulos,
P. Pantelidis,
...
P. Haslam,
D. Vassilakis,
C. Black,
R. D. du Bois
|
9 |
2002 |
9
🐢
|
|
🐜
|
Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis.
7 auth.
Brigham C. Willis,
J. Liebler,
K. Luby‐Phelps,
A. Nicholson,
E. Crandall,
R. D. du Bois,
...
Z. Borok
|
9 |
2005 |
9
🐜
|
|
🐢
|
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
18 auth.
R. Hoyles,
R. Ellis,
Jessica Wellsbury,
B. Lees,
P. Newlands,
N. Goh,
C. Roberts,
S. Desai,
A. Herrick,
N. McHugh,
...
N. Foley,
S. Pearson,
P. Emery,
D. Veale,
C. Denton,
A. Wells,
C. Black,
R. D. du Bois
|
9 |
2006 |
9
🐢
|
|
🐜
|
BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis.
11 auth.
T. King,
K. Brown,
G. Raghu,
R. D. du Bois,
D. Lynch,
F. Martinez,
...
D. Valeyre,
I. Leconte,
A. Morganti,
S. Roux,
J. Behr
|
9 |
2011 |
9
🐜
|
|
🐜
|
Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography.
9 auth.
A. Wells,
S. Desai,
M. Rubens,
N. Goh,
D. Cramer,
A. Nicholson,
...
T. Colby,
R. D. du Bois,
D. Hansell
|
9 |
2003 |
9
🐜
|
|
🐜
|
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
16 auth.
R. Baughman,
M. Drent,
M. Kavuru,
M. Judson,
U. Costabel,
R. D. du Bois,
C. Albera,
M. Brutsche,
Gerald S. Davis,
J. Donohue,
...
J. Müller‐Quernheim,
R. Schlenker‐Herceg,
S. Flavin,
K. Lo,
B. Oemar,
E. Barnathan
|
9 |
2006 |
9
🐜
|
|
🐜
|
Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project.
26 auth.
W. Travis,
G. Hunninghake,
T. King,
D. Lynch,
T. Colby,
J. Galvin,
K. Brown,
M. Chung,
J. Cordier,
R. D. du Bois,
K. Flaherty,
T. Franks,
D. Hansell,
T. Hartman,
E. Kazerooni,
...
D. S. Kim,
M. Kitaichi,
T. Koyama,
F. Martinez,
S. Nagai,
D. Midthun,
N. Müller,
A. Nicholson,
G. Raghu,
M. Selman,
A. Wells
|
8 |
2008 |
8
🐜
|
|
🦁
|
Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference.
13 auth.
R. D. du Bois,
D. Weycker,
C. Albera,
W. Bradford,
U. Costabel,
A. Kartashov,
T. King,
L. Lancaster,
P. Noble,
S. Sahn,
...
M. Thomeer,
D. Valeyre,
A. Wells
|
8 |
2011 |
8
🦁
|
